Skye Global Management LP Nautilus Biotechnology, Inc. Transaction History

Skye Global Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.55 - $2.47 $265,515 - $423,111	-171,300 Reduced 75.13%	56,700 $102,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.13 $63,700 - $101,725	32,500 Added 16.62%	228,000 $483,000
Q2 2022 Aug 15, 2022	SELL	$2.64 - $4.84 $2,640 - $4,840	-1,000 Reduced 0.51%	195,500 $526,000
Q1 2022 May 16, 2022	BUY	$3.5 - $5.3 $302,750 - $458,450	86,500 Added 78.64%	196,500 $853,000
Q4 2021 Feb 14, 2022	BUY	$4.45 - $6.21 $287,025 - $400,545	64,500 Added 141.76%	110,000 $570,000
Q3 2021 Nov 15, 2021	BUY	$6.14 - $10.1 $64,470 - $106,050	10,500 Added 30.0%	45,500 $279,000
Q2 2021 Aug 16, 2021	BUY	$9.04 - $14.19 $316,399 - $496,650	35,000 New	35,000 $354,000

63.9M

2.9K

500

Ticker NAUT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,663,000
Market Cap $324M
Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...

Get notified when there are updates to the investment portfolio of Skye Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Skye Global Management LP with notifications on news.